Announced Tue, 12 May · 15:03 IST

Pursuant to Reg.30 of SEBI (LODR) Regulations, 2015, we are pleased to provide hereunder the proceedings of Extraordinary General Meeting (EGM) of the Company held on Tuesday, May 12, 2026 ....

Board & Shareholder Meetings View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-2.7%1-day move
₹9.97
prior close
₹9.94
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-1.2-0.6-0.5-2.7-4.9-4.0-8.3+9.8+10.9+12.3+6.4-2.4
Up moveDown movePending
AI summary

Gennex Laboratories Limited held an Extraordinary General Meeting on May 12, 2026 via video conferencing. The meeting was attended by 47 members and lasted about 48 minutes. The sole agenda item was the regularization of Ms. Khushbu Kachhawa (DIN: 10872432) as a Non-Executive Independent Woman Director, which required a Special Resolution. She was previously appointed as an Additional Director, and this EGM was convened to regularize her appointment within the three-month timeline mandated by SEBI regulations. Voting was conducted electronically through remote e-voting (May 8-11, 2026) and e-voting at the EGM. Ms. Sweety Kapoor served as Scrutinizer, and the consolidated voting results will be submitted to the stock exchange within prescribed timelines.

Likely market impact

The regularization of Ms. Khushbu Kachhawa as an Independent Woman Director strengthens board compliance with corporate governance norms. This is a routine governance matter with neutral impact on the stock.